NCT03572322

Brief Summary

This survey will assess discrepancies between official clinical genetics guidelines and practices within 3 West regions of France.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 18, 2017

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 18, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 28, 2018

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 13, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 13, 2022

Completed
Last Updated

April 19, 2023

Status Verified

April 1, 2023

Enrollment Period

4.6 years

First QC Date

June 18, 2018

Last Update Submit

April 18, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Characteristics of the determining factors

    Characteristics of the determining factors (medical, sociological, ethical and legal) in the medical practices during the implementation of an ECGP

    through study completion, an average of 1 year

Study Arms (2)

Doctors

Other: Focus Group

Patients

Other: Interviews

Interventions

Focus Group

Doctors

Interviews

Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

genetics tests

You may qualify if:

  • Specialists in Oncology, Endocrinology, Neurology and Medical Genetics
  • Doctors who have already received and returned genetics tests results
  • Main hospital exercise (CHU, CH, CRLCC) on the territory of the HUGO interregion regrouping the administrative regions Bretagne, Pays-de-Loire and Centre
  • Adults who having benefited genetics tests
  • Ability to express oneself easily in French and whose clinical situation allows it

You may not qualify if:

  • liberal doctor
  • Patient refusing to participated in the study
  • Medical contraindication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Rennes

Rennes, 35 033, France

Location

MeSH Terms

Interventions

Focus GroupsInterviews as Topic

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Laurent Pasquier, MD

    Rennes University Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2018

First Posted

June 28, 2018

Study Start

September 18, 2017

Primary Completion

April 13, 2022

Study Completion

April 13, 2022

Last Updated

April 19, 2023

Record last verified: 2023-04

Locations